StreetInsider.com News Articles

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

LONDON & BOSTON--(BUSINESS WIRE)-- Convatec, a global medical products and technologies company focused on solutions for the management of chronic conditions, has been awarded two group purchasing agreements in the Enterostomal Therapy Products category with Premier, Inc., effective April 1, 2026:

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.

Mon, 09 Feb 2026 09:00:00 -0500

National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products.
AscenDrive® Agreement: Convatec has also been awarded a group purchasing agreement for enterostomal therapy products with Premier’s AscenDrive® program, which is designed to drive the highest-level commitment and savings for members

Convatec Selects LTIMindtree for Strategic, AI-Powered SAP S/4HANA Transformation

Mon, 17 Nov 2025 03:30:00 -0500

LONDON & MUMBAI, India--(BUSINESS WIRE)-- LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced its selection as a strategic partner by Convatec, a leading global medical products and technologies company, for the implementation of SAP’s Digital Core – S/4HANA. As part of this engagement, LTIMindtree will support Convatec to implement SAP’s Digital Core – S/4HANA across its Convatec’s business operations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251114580133/en/

Srini Rao, EVP and
</article>
<article>
<h1>Convatec Selects LTIMindtree for Strategic, AI-Powered SAP S/4HANA Transformation</h1>
<p>Mon, 17 Nov 2025 03:30:00 -0500</p>
<p> LONDON & MUMBAI, India--(BUSINESS WIRE)--
<a target=

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced its selection as a strategic partner by Convatec, a leading global medical products and technologies company, for the implementation of SAP’s Digital Core – S/4HANA. As part of this engagement, LTIMindtree will support Convatec to implement SAP’s Digital Core – S/4HANA across its Convatec’s business operations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251114580133/en/

Srini Rao, EVP and
</article>
<article>
<h1>Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research</h1>
<p>Mon, 27 Oct 2025 08:00:00 -0500</p>
<p> LONDON & BOSTON--(BUSINESS WIRE)--
<b>Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. <i>Perspectives on living with chronic conditions </i>– research undertaken in the United States, United Kingdom, Germany, Italy, and Brazil – shows that while one in three people1 surveyed lives with a chronic physical condition, nearly 60% routinely downplay their symptoms to avoid making other people feel uncomfortable.</b>

</p><p>
<b>Key findings</b>

</p><ul class=

Chronic conditions are widespread

Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research

Mon, 27 Oct 2025 08:00:00 -0500

LONDON & BOSTON--(BUSINESS WIRE)-- Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the United States, United Kingdom, Germany, Italy, and Brazil – shows that while one in three people1 surveyed lives with a chronic physical condition, nearly 60% routinely downplay their symptoms to avoid making other people feel uncomfortable.
Key findings

Chronic conditions are widespread

Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research

Mon, 27 Oct 2025 08:00:00 -0500

LONDON & BOSTON--(BUSINESS WIRE)-- Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the United States, United Kingdom, Germany, Italy, and Brazil – shows that while one in three people1 surveyed lives with a chronic physical condition, nearly 60% routinely downplay their symptoms to avoid making other people feel uncomfortable.
Key findings

Chronic conditions are widespread

Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research

Mon, 27 Oct 2025 08:00:00 -0500

LONDON & BOSTON--(BUSINESS WIRE)-- Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the United States, United Kingdom, Germany, Italy, and Brazil – shows that while one in three people1 surveyed lives with a chronic physical condition, nearly 60% routinely downplay their symptoms to avoid making other people feel uncomfortable.
Key findings

Chronic conditions are widespread

Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research

Mon, 27 Oct 2025 08:00:00 -0500

LONDON & BOSTON--(BUSINESS WIRE)-- Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the United States, United Kingdom, Germany, Italy, and Brazil – shows that while one in three people1 surveyed lives with a chronic physical condition, nearly 60% routinely downplay their symptoms to avoid making other people feel uncomfortable.
Key findings

Chronic conditions are widespread